Feb 04, 2016 20:15 pm UTC| Business
SALT LAKE CITY, Feb. 04, 2016 -- Sera Prognostics, Inc., a women’s healthcare company, today announced that results from the 5,501-patient Proteomic Assessment of Preterm Risk (PAPR) study validate the newly available...
Kurzweil Education Launches New Version of Flagship K3000+firefly for Web Customers
Feb 04, 2016 20:00 pm UTC| Business
DALLAS, Feb. 04, 2016 -- Kurzweil Education™, a division of Cambium Learning® Group, Inc., today announced the availability of a new update for k3000+firefly subscribers: a next-generation interface with an even easier...
Feb 04, 2016 19:54 pm UTC| Business
ST. MICHAEL, Minn., Feb. 4, 2016 -- Meet face-to-face with water jet technology and metal fabrication experts from Jet Edge and Elliott-Matsuura Canada at the Metalworking Manufacturing Production Expo, 10 a.m.-4 p.m....
Feb 04, 2016 19:49 pm UTC| Business
Copenhagen, Feb. 4, 2016 -- In response to market speculation about patent litigation in the US relating to lixisenatide, Zealand informs that it is not a party to the US proceedings. Zealand is aware of the patent...
Feb 04, 2016 19:47 pm UTC| Business
The Phase 2 trial is an important step in the dual product development of ZP4207: both as a rescue pen to treat severe hypoglycemia and as an essential component in an artificial pancreas device for better diabetes...
Feb 04, 2016 19:30 pm UTC| Business
BROOMFIELD, Colo., Feb. 04, 2016 -- Huntington Ingalls Industries (NYSE:HII) announced today that its SN3 subsidiary will participate in the 8(a) Business Development Mentor-Protégé Program. SN3 will work...
Feb 04, 2016 19:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 04, 2016 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...